So Henderson leaves Cardinal Health (~$28b market cap) as CFO and joins BOD of FGEN (~$1.2B market cap); think he can see the potential? Guys like this don't make this kind of investment of their time w/o very careful calculations. It's good FGEN has this expertise, as well, as it's likely to get much bigger imo.
It's just a typical post GS upgrade dump, back to the bottom of the upchannel. Should trend higher from here, imo. Next "event" that i am looking at is the CC associated w/ the ER, and I think the price will appreciate into ER (~30 days from now i think). Top of channel is about 30, the way I measure it. GL.
This is good news, and follows directly on to the company's 6/10 presentation. DMD is a really significant potential use of 3019. Anticipation of good things coming out of this study is going to help the stock on an ongoing basis, imo, as it should. Second half '15 continues to look good. gl.
All the big vol is on up days. Stock got pushed back a little from the $24 resistance shelf. I think it will be $28 or so by the next ER; people (incl me) will be excited to see/hear about the follow through progress made since the positive GS conference update. Lots to look forward to here in H2 I think.